Serena Mandla
Co-Founder & Chief Scientific Officer Noa Therapeutics
Serena is the Chief Scientific Officer at Noa Therapeutics and a biomedical engineer with 10 years of experience spanning immune mediated tissue engineering strategies, company creation and drug development.
Seminars
Thursday 21st May 2026
Panel Discussion: Leveraging Cross-Sector Partnerships: How Small Biotechs Navigate Big Pharma Interest in Dermatology
2:00 pm
- What data packages de-risk acquisition or licensing for large pharma?
- How do biotechs time interactions with BD teams and investment banks?
- What distinguishes “interesting science” from investable clinical programs?
